covid vaccine novavax

Order byBest matchMost fresh

Novavax scores narrower Covid vaccine approval

FDA gives Covid vaccine manufacturers instructions for next fall’s shot

The Food and Drug Administration gave Covid vaccine manufacturers instructions on what next fall’s Covid vaccines should target on Thursday, signaling it would prefer that they update the strain in t...

STAT · 1h

Infectious Disease Advisor · 1d

FDA Approves Novavax’s COVID-19 Vaccine Nuvaxovid

WebMD · 2d

FDA Approves Novavax COVID Vaccine With Restricted Use

FDA tightens requirements for COVID vaccine, adding trials for healthy adults

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day.

· 1d

· 2d

F.D.A. Poised to Restrict Access to Covid Vaccines

· 1d

New Trump vaccine policy limits access to COVID shots

US FDA Advisers to Weigh Composition of COVID Vaccines for 2025-2026

Public health experts say that there is no certainty on which strains are going to be dominant.

· 11h

· 1d

FDA plans to limit COVID vaccine to only high-risk people. Who would still be eligible?

· 12h

FDA panel debates COVID vaccine recipe as questions swirl about fall shots

2don MSN

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's Covid-19 vaccine after more than a month of delay b

1don MSN

Who can get updated COVID vaccines this fall? FDA will OK for high-risk groups, calls for new clinical trials

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

BioPharma Dive2h

FDA panel recommends keeping COVID shots targeted to same strain as last year

The advisory committee, which met after the agency rolled out new vaccine guidelines, said companies should tailor their booster doses to the “JN.1” coronavirus lineage.